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Abstract
Background—Cardiovascular risk factors are associated with a higher risk of developing
dementia. Studies in older populations, however, have often failed to show this relationship. We
assessed the association between cardiovascular risk factors measured in midlife and risk of being
hospitalized with dementia and determined whether this association was modified by age and
ethnicity.
Methods—We studied 11,151 participants in the population-based Atherosclerosis Risk in
Communities cohort, aged 46-70 (23% African Americans) in 1990-1992, when participants
underwent a physical exam and cognitive testing. Hospitalizations with dementia were ascertained
through December 2004.
Results—During follow-up, 203 cases of hospitalization with dementia were identified. Smoking
(hazard ratio (HR), 95% confidence interval (CI): 1.7, 1.2-2.5), hypertension (HR, 95% CI: 1.6,
1.2-2.2) and diabetes (HR, 95% CI: 2.2, 1.6-3.0) were strongly associated with dementia, both in
whites and African-Americans. These associations were stronger when risk factors were measured
at younger age than at older age. In analyses including updated information on risk factors during
follow-up, the HR of dementia in hypertensive versus non-hypertensive participants was 1.8 at age
<55 years compared to 1.0 at age 70+ years. Parallel results were observed for diabetes (HR 3.4 in
<55, 2.0 in ≥70), smoking (4.8 in <55, 0.5 in ≥70), and hypercholesterolemia (HR 1.7 in <55, 0.9
in ≥70)
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Conclusion—In this prospective study, smoking, hypertension, and diabetes were strongly
associated with subsequent risk of hospitalization with dementia, particularly in middle aged
individuals. Our results emphasize the importance of early lifestyle modification and risk factor
treatment to prevent dementia.
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Introduction
Dementia is one of the major public health problems affecting the elderly in developed
countries. Estimates in the United States (US) show that 1 in 6 individuals older than 70
have dementia, with prevalence increasing exponentially with advanced age.[1,2] As the
elderly population grows, the number of affected individuals, as well as the costs and social
burden associated with dementia, will soar. United States population projections suggest that
the number of dementia cases in 2050 will increase 3-fold compared to the year 2000.[3]
The most common forms of dementia in the general population are Alzheimer's disease and
vascular dementia.[4] Alzheimer's disease is the diagnosis given in approximately 70% of
total dementia cases, while 20% are labeled as vascular dementia, the rest being ascribed to
miscellaneous etiologies.[1] Nonetheless, pathological evidence has shown considerable
overlap between Alzheimer's disease and vascular dementia,[5] suggesting that Alzheimer's
disease could be considered a vascular disease or has a vascular component.[6] Some degree
of vascular involvement, particularly microvascular disease, is generally present in
Alzheimer's disease cases, though to what degree alterations in the microvasculature are
caused by or predispose to Alzheimer's disease remains unresolved.[7]
Different epidemiologic studies have found that the presence of cardiovascular risk factors,
including hypertension, diabetes, obesity or smoking, increases the risk of developing
subsequent dementia, including Alzheimer's disease.[8-12] These observations further
advance the case for a vascular involvement in the pathogenesis of dementia in general, and
Alzheimer's disease in particular. However, randomized trials of anti-hypertensive
medications for the prevention of dementia in older individuals have been disappointing,
showing no protective effect.[13] This apparent contradiction could be attributed to a
significant predictive and etiologic role of cardiovascular risk factors in midlife but not in
older ages. A recent review of prospective studies assessing the association of smoking and
dementia showed that smoking predicted the risk of dementia only if measured in midlife.
[14] The same phenomenon has been described for the link between hypertension and
dementia.[15] The studies included in these two reviews, however, compared results from
different populations and did not address directly whether age modified the effect of
cardiovascular risk factors on dementia. Further evidence derived from prospective studies
in which vascular risk factors and cognition were measured both in middle and older age is
required.
Until now, studies on cardiovascular risk factors and dementia have examined mostly white
populations, with the exception of the Honolulu Asia Aging Study, which studied Japanese-
Americans residing in Hawaii.[16] The prevalence of both dementia and some
cardiovascular risk factors is higher among African-Americans,[2,17,18] but the role of
vascular risk factors in dementia incidence in African-Americans is largely unstudied.
Our objective was to evaluate the association of cardiovascular risk factors with the
incidence of dementia defined through hospital discharge codes in whites and African-
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Americans enrolled in the Atherosclerosis Risk in Communities (ARIC) study, a population-
based prospective study in the US, and to determine whether the age at which the risk
factors were measured modified this association.
Methods
Study population
The ARIC study is a population-based cohort including 15,792 men and women, aged
45-64, recruited during 1987-1989 from four communities in the US (Forsyth County, North
Carolina; Jackson, Mississippi; Washington County, Maryland; suburbs of Minneapolis,
Minnesota).[19] Its main objective was to investigate the major determinants of
atherosclerosis in the general population. ARIC participants were examined at baseline and
three more times approximately every three years (last exam 1996-1998). Response rates
among survivors for the successive examinations were 93%, 86% and 80%. Additionally,
annual phone follow-up calls are made to all surviving cohort members (93% response rate
on average).
The second ARIC examination, conducted in 1990-1992, included a cognitive assessment.
For the purpose of this analysis, we restricted our sample to ARIC participants who attended
the second examination and were white from Minnesota, Washington County, and Forsyth
County communities, or African-American from Jackson and Forsyth County (n=14,257).
Ninety-one participants were excluded for failing to meet racial/ethnic criteria. Individuals
meeting any of the following criteria at the second examination were excluded: history of
coronary heart disease, stroke, or transient ischemic attack (n=1,537), missing information
on any of the study covariates (n=488), and scoring below sex- and race-specific 5th
percentile in any of the cognitive tests to exclude potential prevalent cases of dementia
(n=1,492) (see below).
The study was approved by the Institutional Review Boards at each participating center.
ARIC participants provided written informed consent.
Exposures measurement
In each study exam, ARIC participants gave detailed information on lifestyles, use of
medication and history of previous disease. They underwent a physical examination,
including blood pressure, weight, and height measurements. Blood pressure was taken with
a random-zero sphygmomanometer; the mean of the last 2 of 3 measurements was used for
analysis. Hypertension was defined as having a systolic blood pressure ≥140 mmHg or
diastolic blood pressure ≥90 mmHg or having used antihypertensive medication in the two
weeks before the examination. Height and weight were measured with the participants
wearing a scrub suit and no shoes. Body mass index was calculated as weight in kilograms
divided by height in meters squared.
Educational level and occupation were determined in the first ARIC examination. Education
was categorized in six levels: grade school or less, high school but no degree, high school
graduate, vocational school, college, and graduate or professional school. Occupation was
classified in 8 broad categories: managerial and professional specialty; technical, sales, and
administrative support; service; farming, forestry, and fishing; precision production, craft,
and repair; operator, fabricators, and laborers; homemakers; and retired. In exams 2 and 4,
ARIC participants underwent a cognitive function assessment. Three neuropsychological
tests, Delayed Word Recall Test,[20] Digit Symbol Substitution Test,[21] and Word Fluency
Test,[22] were administered by trained interviewers. The Delayed Word Recall Test is a
memory test that specifically evaluates verbal learning and recent memory, the Digit Symbol
Alonso et al. Page 3













Substitution Test assess sustained attention and psychomotor speed, and the World Fluency
Test measures the flexibility of verbal thought processes.
Fasting blood samples were obtained in each examination, and plasma, serum, and DNA
isolated. Hypercholesterolemia was defined by total blood cholesterol level ≥240 mg/dL or
the participant taking cholesterol-lowering drugs in the 2 weeks prior to the examination.
Diabetes was defined as fasting blood glucose ≥126 mg/dL, or non-fasting blood glucose
≥200 mg/dL, or a self-reported history of or treatment for diabetes. Genotyping of the APOE
polymorphisms was performed using the TaqMan assay (Applied Biosystems, Foster City,
CA) with variants at codons 130 and 176 (formerly 112 and 158) assayed separately. The
data from these two codons were combined to generate the six APOE genotypes. The ABI
7900 and Sequence Detection System software (Applied Biosystems) was used for allele
detection and genotype calling.[23] Genotypes were classified as: ε2/ε2+ε2/ε3, ε3/ε3
(reference), ε2/ε4+ε3/ε4, ε4/ε4.
Outcome ascertainment
The main outcome of interest for this analysis was incident dementia identified through
ARIC follow-up for all hospitalizations by December 31, 2004 and chart abstraction of all
hospital discharge codes. Hospitalizations in ARIC are identified by participant or proxy
report in the annual follow-up and by surveillance of local hospital discharge lists. The
ICD-9 codes used to define dementia referred to Alzheimer's disease (331.0), vascular
dementia (290.4) or any other code that could have been used for dementia of other etiology
(290.0, 290.1, 290.2, 290.3, 290.9, 294.1, 294.2, 294.8, 294.9, 331.1, 331.2, 331.8, 331.9).
First occurrence of any of these codes was considered the event time. A rough assessment of
the validity of this outcome was performed, first, computing age, sex and race-specific
incidence rates of a first hospitalization with dementia and comparing them to previous
studies, and, second, estimating the association between APOE genotype, a well-established
risk factor for dementia, and the outcome. Because we excluded ARIC participants with low
scores in any of the cognitive tests at exam 2, we assumed cases to be new (incident) events.
Statistical analysis
Specific incidence rates of dementia were estimated by dividing the number of new cases of
dementia hospitalization in each age- (in 5-year periods), sex-, and race-specific group by
the number of corresponding person-years. Follow-up for each study participant was defined
as the time between exam 2 and occurrence of hospitalization with dementia, death, loss to
follow-up, or December 31, 2004, whichever occurred earlier. We estimated hazard ratios
(HR) of dementia and their 95% confidence intervals (CI) by presence of cardiovascular risk
factors at baseline using Cox proportional hazard models, with time from exam 2 to
dementia hospitalization as the dependent variable. Initial models adjusted for age, sex, race,
educational level, occupation, study center, and scores in the cognitive assessment. A second
model adjusted additionally for the presence of other cardiovascular factors. Analyses were
repeated not including baseline cognitive scores as covariates. Finally, APOE genotype,
considered as a potential confounder for the association between cardiovascular disease and
risk of dementia, was included in the model. We ran stratified analyses by race, sex, age
(<60, ≥60 at baseline) and APOE genotype (ε4 allele present or not), and estimated potential
interactions with these variables using the likelihood ratio test.
To estimate the difference in associations by age at baseline and to take advantage of the
repeated measures in the follow-up, we created two additional cohorts using exams 3 and 4
as baseline, excluding individuals who had a dementia hospitalization before the exam,
additionally applying the same exclusion criteria as for the main analysis, and using
information on risk factors measured at those examinations. Subsequently, we pooled
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together the three cohorts in one Cox model, including the same potential confounders as in
the main analysis. Because each study participant could be included more than once, we
used a robust variance estimator to take into account within-individual correlations.[24] We
stratified the analysis by age in the following categories: <55, 55-59, 60-64, 65-69, and ≥70.
We additionally tested whether, in non-demented survivors at exam 4, cardiovascular risk
factors measured in exam 2 were better predictors of dementia hospitalization than
measurements in exam 4.
Results
From 14,348 participants attending the second examination, 11,151 met inclusion criteria.
Figure 1 shows each of the reasons for exclusion. Selected characteristics of the included
study participants are presented in table 1. As reported previously, the prevalence of
hypertension, obesity and diabetes was higher in African-Americans compared to whites.
We identified 203 cases of hospitalization with dementia during 142,625 person-years of
follow-up (average follow-up: 12.8 years). Mean age at first dementia hospitalization was
71.7 (standard deviation: 5.9). Figure 2 depicts the age, sex, and race-specific incidence
rates of hospitalization with dementia. Rates increased exponentially with age in men and
women, and in African-Americans and whites. Overall, African-Americans had higher rates
than whites. Scores in the Delayed Word Recall and Digit Symbol Substitution tests (p-
value<0.0001 for both tests), but not in the Word Fluency Test (p-value=0.74), were
predictors of the risk of dementia (figure 3). The proportion of individuals with
cardiovascular disease as a primary diagnosis in hospitalizations with dementia (19%) was
lower than that observed in the entire ARIC sample (29%).
Presence of the APOE ε4 allele was associated with an increased risk of dementia.
Individuals with at least one ε4 allele had an 80% increase in the incidence of dementia
compared to those without ε4 allele (HR 1.8, 95% CI 1.4, 2.4). This association followed a
dose-response model. Compared to individuals with ε3/ε3 genotype, the HR (95% CI) of
dementia hospitalization for ε3/ε4 and ε4/ε4 genotypes were 1.4 (0.9-2.1) and 4.6 (2.5-8.7)
in whites and 1.8 (1.1-3.0) and 2.9 (1.2-6.9) in African-Americans (p-trend<0.001 and p-
interaction=0.32).
Associations between the main cardiovascular risk factors and dementia hospitalization are
shown in table 2. Smoking, hypertension, and diabetes were associated with a higher risk of
the outcome, while there was no association between obesity/overweight or
hypercholesterolemia, and dementia. Results were similar across APOE genotype
categories, when baseline cognitive scores were not included in the analysis as covariates or
when participants with cardiovascular disease at baseline were included (not shown).
Associations between cardiovascular risk factors and dementia were similar in whites and
African-Americans (table 2), and men and women (data not shown). Age, however,
interacted significantly with the presence of cardiovascular risk factors: the associations
were stronger among individuals younger than 60 at baseline (table 3). Figure 4 presents
results from an analysis that combines data using exams 2, 3 and 4 as separate baseline
measures to classify individuals in the appropriate age group at each visit and update their
risk factor information. The relative hazard of dementia associated to the different
cardiovascular risk factors, with the exception of obesity, decreased with increasing age.
Finally, in an analysis restricted to non-demented survivors in exam 4, exam 2
measurements were slightly better predictors of dementia hospitalization than exam 4
measurements: the HR (95% CI) of dementia for exam 2 vs. exam 4 measurements were 1.7
(1.0-2.8) vs. 1.5 (0.9-2.6) (smoking), 1.5 (1.0-2.2) vs. 1.4 (0.9-2.1) (hypertension), and 2.3
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(1.5-3.6) vs. 2.0 (1.3-3.1) (diabetes). Average age at visit 2 and visit 4 for these ARIC
participants was 56.4 and 62.5 respectively.
Discussion
In this population-based prospective cohort study, we found that hypertension, diabetes, and
smoking measured in midlife were strongly associated with an increased risk of being
hospitalized with dementia later in life. The associations were similar in whites and African-
Americans, and persisted after adjustment for dementia risk factors including APOE
genotype and cognitive function at baseline. Associations were stronger when risk factors
were measured at a younger age. Results from previous observational studies conducted in
Caucasian and Asian populations have shown that cardiovascular risk factors, including
hypertension, diabetes, obesity/overweight and smoking, are associated with a higher risk of
developing dementia.[8-12,25-28] The present study extends the results to African-
Americans.
Cardiovascular risk factors can lead to vascular disease in the brain by causing multi-
infarcts, manifested as classic vascular dementia, as well as small vessel disease (lacunes
and smaller infarcts, white matter lesions, and arteriolar changes).[29,30] The burden of
cerebral small vessel disease, in turn, is a major contributor to cognitive decline and
dementia.[31,32] Diabetes, hypertension, and smoking were the factors more strongly
associated with the risk of dementia hospitalization in this sample, probably as a
consequence of their potential role on microvascular disease and occurrence of white matter
lesions.[30,33]
In the present study, cardiovascular risk factors measured in midlife were stronger predictors
of dementia hospitalization than factors measured in older age. This observation, which
confirms our a priori hypothesis, has several possible explanations. First, cardiovascular risk
factors could have a cumulative effect, with increased risk of dementia if an individual has
suffered hypertension or diabetes, or has smoked for a longer period of time. Second,
midlife measures could better predict future risk of dementia if individuals susceptible to
develop dementia caused by vascular risk factors did so before reaching older age. As a
result, older samples would be somewhat depleted of individuals vulnerable to
cardiovascular risk factors.[14] Third, a diagnosis of dementia could be more easily
overlooked in older individuals, with a greater number of co-morbidities, than in younger
individuals. Finally, cardiovascular risk factors may lead to secondary changes including
illness (e.g. heart failure, weight loss) and behavioral modification (e.g. smoking cessation
before or after the onset of a vascular event). Such changes and better control of risk factors
in older than younger individuals would diminish associations of cardiovascular risk factors
measured at older age with subsequent risk. Although control rates of diabetes are higher
among individuals older than 60 in the US,[34] the opposite pattern has been observed for
hypertension.[35] Additionally, our knowledge of the effect of medications for hypertension
and diabetes in older individuals is sparse. Independently of the underlying mechanism, our
results suggest that, for prevention of dementia, control of cardiovascular risk factors
starting in midlife is likely to be more important in the prevention of dementia than control
starting later on. Our results may also help explain the lack of cognitive benefit found in
most [36-39] but not all [40] antihypertensive clinical trials whose follow-up was only 3-5
years.
The study has a number of limitations including the endpoint ascertainment. Cases were
individuals with dementia who were hospitalized and dementia was included among their
discharge diagnoses. Dementia hospitalizations likely underestimate disease. In fact, the
observed age-specific rates are lower than those reported in the Cardiovascular Health Study
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or the Northern Manhattan study.[2,41] This could be problematic if the probability of
hospitalization with dementia depended on the presence of cardiovascular risk factors.
Smokers, hypertensives or diabetics have a higher risk of hospitalization due to
cardiovascular, renal or lung diseases, creating a positive association between these risk
factors and dementia hospitalization. Conversely, the presence of multiple diagnoses in
smokers, hypertensives or diabetics may decrease the probability of the dementia diagnosis
being recorded among the discharge codes and, thereby, creating a downward bias in the
association. Several reasons, however, support the validity of dementia hospitalization as an
adequate proxy for dementia incidence. First, different studies have found a high positive
predictive value for dementia ICD discharge code.[42,43] Second, the strong association of
poor cognitive scores with dementia hospitalization, a factor unlikely to lead by itself to
hospitalization, suggests that our study is identifying true cases of dementia. Finally, an
overall higher risk of hospitalization in individuals with cardiovascular risk factors could not
easily explain the interaction between these factors and age.
Our study has several strengths. Cardiovascular risk factors were assessed before the age of
higher risk of dementia, reducing the risk of reverse causation. Also, measurements of
cognitive function allowed the exclusion at baseline of individuals with possible early
dementia. Other covariates that could act as confounders were determined in the different
study visits, including sociodemographic variables, lifestyles and APOE genotype. Finally,
the ARIC cohort comprises a large, representative, and racially diverse sample, facilitating
the generalizability of the results.
In conclusion, we have observed that hypertension, diabetes and smoking in midlife are
associated with a higher risk of dementia hospitalization. We present one of the only studies
demonstrating this association in African-Americans, showing that they have a higher risk of
dementia hospitalization as well as higher level of cardiovascular risk factors. Our results
directly demonstrate that cardiovascular risk factors in midlife play an important role in the
development of dementia at older age despite a weaker association when the risk factors are
measured at older age. These results suggest that smoking cessation and prevention or
control of hypertension and diabetes starting in midlife may have the added benefit of
decreasing dementia hospitalization risk. Physiologic pathways and intermediate cerebral
changes detectable by non-invasive imaging involved in the vascular pathophysiology of
dementia should be studied, since clinical trials might require a decade or more of treatment
to fully realize a benefit on dementia prevention.
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Study participants flow diagram.
ARIC: Atherosclerosis Risk in Communities study. CVD: cardiovascular disease
* Study participants could meet more than one exclusion criteria
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Incidence of hospitalization with dementia by age, sex and race. ARIC study, 1990-2004.
Age-adjusted hazard ratio (HR) (95% confidence interval) is 2.5 (1.9, 3.3) for African-
Americans vs. whites and 1.0 (0.7, 1.3) for men vs. women.
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Hazard ratios of dementia hospitalization by quartiles of cognitive score at exam 2 for the
entire sample, and for race and age groups separately. Analyses adjusted for age, sex, race
and study center. DWR: Delayed Word Recall Test; DSS: Digit Symbol Substitution Test;
WF: Word Fluency Test. P-value for trend estimated for cognitive score as a continuous
variable.
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Hazard ratios and 95% confidence intervals (CI) of dementia associated with the presence of
each cardiovascular risk factor, by age at study exam. Cox proportional hazards model
adjusted for age, gender, race, study center, educational level, occupation, cognitive test
scores at exam 2 and cardiovascular risk factors. P for trend corresponds to an interaction
term between age as a continuous variable and the corresponding risk factor. Smoking:
current vs. never smokers. Obesity: >=30 kg/m2 vs. 20-25 kg/m2
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Table 1
Selected characteristics of individuals included in the follow-up at exam 2. ARIC study, 1990-1992
Whites African-Americans
Women Men Women Men
N 4713 3819 1696 923
Age (years) 56.6 (5.6) 57.1 (5.6) 55.6 (5.6) 55.7 (5.6)
 [range] 47 – 70 47 – 68 46 – 70 47 – 70
Education (%):
 Less than high school 11.5 11.5 31.7 33.6
 Completed high school 52.0 39.2 31.7 27.9
 College education 36.5 49.2 36.6 38.6
Current smoker (%) 20.5 20.4 20.2 33.5
BMI (kg/m2) 26.8 (5.5) 27.6 (4.0) 31.1 (6.5) 28.1 (5.0)
Hypertension (%) 25.5 29.0 53.1 48.9
Diabetes (%) 8.7 11.9 22.9 20.8
Hypercholesterolemia (%) 26.9 18.9 25.1 20.3
Results of cognitive tests:
 Delayed word recall 7.2 (1.2) 6.6 (1.3) 6.6 (1.4) 6.1 (1.4)
 Digit symbol substitution 53.4 (10.0) 47.9 (9.9) 35.2 (12.5) 30.5 (11.7)
 Word fluency 37.4 (10.7) 35.8 (11.1) 30.4 (11.8) 29.6 (13.2)
Values refer to means (standard deviation) unless otherwise stated
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